Relationships between viral load, severity of illness, and transmissibility of virus are
fundamental to understanding pathogenesis and devising better therapeutic and prevention …

While it is now widely accepted that host inflammatory responses contribute to lung injury,
the pathways that drive severity and distinguish coronavirus disease 2019 (COVID-19) from …

Background Most studies of immunity to SARS-CoV-2 focus on circulating antibody, giving
limited insights into mucosal defences that prevent viral replication and onward transmission. …

Many patients report persistent symptoms after resolution of acute COVID-19, regardless of
SARS-CoV-2 variant and even if the initial illness is mild [1, 2]. A multitude of symptoms have …

The definition of a high-sensitivity cardiac Troponin (cTn) assay describes the ability to quantify
a cardiac biomarker level in at least 50% of healthy individuals. This advance in analytic …

Objectives The amount of SARS-CoV-2 detected in the upper respiratory tract (URT viral
load) is a key driver of transmission of infection. Current evidence suggests that mechanisms …

One in ten severe acute respiratory syndrome coronavirus 2 infections result in prolonged
symptoms termed long coronavirus disease (COVID), yet disease phenotypes and …

All healthcare systems are increasingly reliant on health information technology to support
the delivery of high-quality, efficient and safe care. Data on its effectiveness are however …

A multipronged approach has been developed for the treatment of COVID-19 disease: antivirals
and antibody therapy are effective during early infection when the SARS-CoV-2 load is …

Background The symptoms, radiography, biochemistry and healthcare utilisation of patients
with COVID-19 following discharge from hospital have not been well described. Methods …